USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and ...

Cipla launches Afrezza, an orally inhaled insulin powder for diabetes patients in India. A needle-free alternative to ...

Fathers exposed to microplastics before conception may be setting their daughters up for metabolic problems later in life.

Manufactured by Connecticut-based biopharmaceutical company MannKind Corporation, Afrezza was first launched in the United ...

Cipla has launched Afrezza, an inhaled rapid-acting insulin for adults with diabetes, after CDSCO approval, and plans an ...

Relearning balance through everyday meals i.e. how traditional Indian foods, chosen mindfully, can support insulin therapy ...

Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by ...

Scott-Moncrieff: The most important first step is deciding which treatment is right for that individual cat, because monitoring differs depending on whether you choose insulin or an SGLT2 ...

Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got ...

For almost two-thirds of his life, Nick Jonas has lived with a chronic condition — type 1 diabetes. The Jonas Brothers-famed ...

The insulin inhalation powder in Afrezza is available in single-use cartridges and is delivered via an inhaler device.

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...